Invention Grant
- Patent Title: Method of treating alveolar bone loss through the use of anti-sclerostin antibodies
-
Application No.: US14362322Application Date: 2012-12-11
-
Publication No.: US09657090B2Publication Date: 2017-05-23
- Inventor: Hua Zhu Ke , Min Liu , William V. Giannobile
- Applicant: AMGEN, INC. , THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Applicant Address: US CA Thousand Oaks US MI Ann Arbor
- Assignee: AMGEN INC.,THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Current Assignee: AMGEN INC.,THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Current Assignee Address: US CA Thousand Oaks US MI Ann Arbor
- Agency: Marshall, Gerstein & Borun LLP
- International Application: PCT/US2012/068975 WO 20121211
- International Announcement: WO2013/101451 WO 20130704
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/395 ; A61K47/06 ; C07K16/18 ; C07K16/22 ; A61K45/06
Abstract:
The invention provides a method of treating alveolar bone loss involving administration of a sclerostin inhibitor to a subject in need thereof.
Public/Granted literature
- US20140314776A1 METHOD OF TREATING ALVEOLAR BONE LOSS THROUGH THE USE OF ANTI-SCLEROSTIN ANTIBODIES Public/Granted day:2014-10-23
Information query
